AEB-5100

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAEB-5100
Drug Alias Namerecombinant human enzyme targeting cystine/cysteine (Aeglea BioTherapeutics)AEB-5100
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsCystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpyre Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpyre Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCystinuria

Other Information

ATC CodeN/A
Related LinksN/A